img

Global Nuclear Drug for Therapeutic Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Nuclear Drug for Therapeutic Market Insights, Forecast to 2034

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
Market Analysis and InsightsGlobal Nuclear Drug for Therapeutic Market
Global Nuclear Drug for Therapeutic market is expected to reach to US$ 2036 million in 2024, with a positive growth of %, compared with US$ 1771 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Nuclear Drug for Therapeutic industry is evaluated to reach US$ 4734 million in 2029. The CAGR will be 15.1% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Nuclear Drug for Therapeutic market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Nuclear Drug for Therapeutic market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant Radiopharma
Lantheus
Aurobindo Pharma
International Isotopes
Mundipharma
Segment by Type
Radium-223
Lutetium-177
Iodine-131
Other

Segment by Application


Thyroid
Bone Metastasis
Lymphoma
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Nuclear Drug for Therapeutic introduction, etc. Nuclear Drug for Therapeutic Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Nuclear Drug for Therapeutic
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Drug for Therapeutic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Market by Application
1.3.1 Global Nuclear Drug for Therapeutic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Drug for Therapeutic Market Perspective (2018-2029)
2.2 Global Nuclear Drug for Therapeutic Growth Trends by Region
2.2.1 Nuclear Drug for Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Nuclear Drug for Therapeutic Historic Market Size by Region (2018-2024)
2.2.3 Nuclear Drug for Therapeutic Forecasted Market Size by Region (2024-2029)
2.3 Nuclear Drug for Therapeutic Market Dynamics
2.3.1 Nuclear Drug for Therapeutic Industry Trends
2.3.2 Nuclear Drug for Therapeutic Market Drivers
2.3.3 Nuclear Drug for Therapeutic Market Challenges
2.3.4 Nuclear Drug for Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Nuclear Drug for Therapeutic by Players
3.1.1 Global Nuclear Drug for Therapeutic Revenue by Players (2018-2024)
3.1.2 Global Nuclear Drug for Therapeutic Revenue Market Share by Players (2018-2024)
3.2 Global Nuclear Drug for Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Nuclear Drug for Therapeutic, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Nuclear Drug for Therapeutic Market Concentration Ratio
3.4.1 Global Nuclear Drug for Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Drug for Therapeutic Revenue in 2022
3.5 Global Key Players of Nuclear Drug for Therapeutic Head office and Area Served
3.6 Global Key Players of Nuclear Drug for Therapeutic, Product and Application
3.7 Global Key Players of Nuclear Drug for Therapeutic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nuclear Drug for Therapeutic Breakdown Data by Type
4.1 Global Nuclear Drug for Therapeutic Historic Market Size by Type (2018-2024)
4.2 Global Nuclear Drug for Therapeutic Forecasted Market Size by Type (2024-2029)
5 Nuclear Drug for Therapeutic Breakdown Data by Application
5.1 Global Nuclear Drug for Therapeutic Historic Market Size by Application (2018-2024)
5.2 Global Nuclear Drug for Therapeutic Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Nuclear Drug for Therapeutic Market Size (2018-2029)
6.2 North America Nuclear Drug for Therapeutic Market Size by Type
6.2.1 North America Nuclear Drug for Therapeutic Market Size by Type (2018-2024)
6.2.2 North America Nuclear Drug for Therapeutic Market Size by Type (2024-2029)
6.2.3 North America Nuclear Drug for Therapeutic Market Share by Type (2018-2029)
6.3 North America Nuclear Drug for Therapeutic Market Size by Application
6.3.1 North America Nuclear Drug for Therapeutic Market Size by Application (2018-2024)
6.3.2 North America Nuclear Drug for Therapeutic Market Size by Application (2024-2029)
6.3.3 North America Nuclear Drug for Therapeutic Market Share by Application (2018-2029)
6.4 North America Nuclear Drug for Therapeutic Market Size by Country
6.4.1 North America Nuclear Drug for Therapeutic Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Nuclear Drug for Therapeutic Market Size by Country (2018-2024)
6.4.3 North America Nuclear Drug for Therapeutic Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Nuclear Drug for Therapeutic Market Size (2018-2029)
7.2 Europe Nuclear Drug for Therapeutic Market Size by Type
7.2.1 Europe Nuclear Drug for Therapeutic Market Size by Type (2018-2024)
7.2.2 Europe Nuclear Drug for Therapeutic Market Size by Type (2024-2029)
7.2.3 Europe Nuclear Drug for Therapeutic Market Share by Type (2018-2029)
7.3 Europe Nuclear Drug for Therapeutic Market Size by Application
7.3.1 Europe Nuclear Drug for Therapeutic Market Size by Application (2018-2024)
7.3.2 Europe Nuclear Drug for Therapeutic Market Size by Application (2024-2029)
7.3.3 Europe Nuclear Drug for Therapeutic Market Share by Application (2018-2029)
7.4 Europe Nuclear Drug for Therapeutic Market Size by Country
7.4.1 Europe Nuclear Drug for Therapeutic Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Nuclear Drug for Therapeutic Market Size by Country (2018-2024)
7.4.3 Europe Nuclear Drug for Therapeutic Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Nuclear Drug for Therapeutic Market Size (2018-2029)
8.2 China Nuclear Drug for Therapeutic Market Size by Type
8.2.1 China Nuclear Drug for Therapeutic Market Size by Type (2018-2024)
8.2.2 China Nuclear Drug for Therapeutic Market Size by Type (2024-2029)
8.2.3 China Nuclear Drug for Therapeutic Market Share by Type (2018-2029)
8.3 China Nuclear Drug for Therapeutic Market Size by Application
8.3.1 China Nuclear Drug for Therapeutic Market Size by Application (2018-2024)
8.3.2 China Nuclear Drug for Therapeutic Market Size by Application (2024-2029)
8.3.3 China Nuclear Drug for Therapeutic Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Nuclear Drug for Therapeutic Market Size (2018-2029)
9.2 Asia Nuclear Drug for Therapeutic Market Size by Type
9.2.1 Asia Nuclear Drug for Therapeutic Market Size by Type (2018-2024)
9.2.2 Asia Nuclear Drug for Therapeutic Market Size by Type (2024-2029)
9.2.3 Asia Nuclear Drug for Therapeutic Market Share by Type (2018-2029)
9.3 Asia Nuclear Drug for Therapeutic Market Size by Application
9.3.1 Asia Nuclear Drug for Therapeutic Market Size by Application (2018-2024)
9.3.2 Asia Nuclear Drug for Therapeutic Market Size by Application (2024-2029)
9.3.3 Asia Nuclear Drug for Therapeutic Market Share by Application (2018-2029)
9.4 Asia Nuclear Drug for Therapeutic Market Size by Region
9.4.1 Asia Nuclear Drug for Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Nuclear Drug for Therapeutic Market Size by Region (2018-2024)
9.4.3 Asia Nuclear Drug for Therapeutic Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Size by Type
10.2.1 Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Size by Application
10.3.1 Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Size by Country
10.4.1 Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Nuclear Drug for Therapeutic Introduction
11.1.4 Bayer Revenue in Nuclear Drug for Therapeutic Business (2018-2024)
11.1.5 Bayer Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Nuclear Drug for Therapeutic Introduction
11.2.4 Novartis Revenue in Nuclear Drug for Therapeutic Business (2018-2024)
11.2.5 Novartis Recent Developments
11.3 China Isotope & Radiation
11.3.1 China Isotope & Radiation Company Details
11.3.2 China Isotope & Radiation Business Overview
11.3.3 China Isotope & Radiation Nuclear Drug for Therapeutic Introduction
11.3.4 China Isotope & Radiation Revenue in Nuclear Drug for Therapeutic Business (2018-2024)
11.3.5 China Isotope & Radiation Recent Developments
11.4 Dongcheng
11.4.1 Dongcheng Company Details
11.4.2 Dongcheng Business Overview
11.4.3 Dongcheng Nuclear Drug for Therapeutic Introduction
11.4.4 Dongcheng Revenue in Nuclear Drug for Therapeutic Business (2018-2024)
11.4.5 Dongcheng Recent Developments
11.5 Q BioMed
11.5.1 Q BioMed Company Details
11.5.2 Q BioMed Business Overview
11.5.3 Q BioMed Nuclear Drug for Therapeutic Introduction
11.5.4 Q BioMed Revenue in Nuclear Drug for Therapeutic Business (2018-2024)
11.5.5 Q BioMed Recent Developments
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Company Details
11.6.2 Curium Pharmaceuticals Business Overview
11.6.3 Curium Pharmaceuticals Nuclear Drug for Therapeutic Introduction
11.6.4 Curium Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2018-2024)
11.6.5 Curium Pharmaceuticals Recent Developments
11.7 Jubilant Radiopharma
11.7.1 Jubilant Radiopharma Company Details
11.7.2 Jubilant Radiopharma Business Overview
11.7.3 Jubilant Radiopharma Nuclear Drug for Therapeutic Introduction
11.7.4 Jubilant Radiopharma Revenue in Nuclear Drug for Therapeutic Business (2018-2024)
11.7.5 Jubilant Radiopharma Recent Developments
11.8 Lantheus
11.8.1 Lantheus Company Details
11.8.2 Lantheus Business Overview
11.8.3 Lantheus Nuclear Drug for Therapeutic Introduction
11.8.4 Lantheus Revenue in Nuclear Drug for Therapeutic Business (2018-2024)
11.8.5 Lantheus Recent Developments
11.9 Aurobindo Pharma
11.9.1 Aurobindo Pharma Company Details
11.9.2 Aurobindo Pharma Business Overview
11.9.3 Aurobindo Pharma Nuclear Drug for Therapeutic Introduction
11.9.4 Aurobindo Pharma Revenue in Nuclear Drug for Therapeutic Business (2018-2024)
11.9.5 Aurobindo Pharma Recent Developments
11.10 International Isotopes
11.10.1 International Isotopes Company Details
11.10.2 International Isotopes Business Overview
11.10.3 International Isotopes Nuclear Drug for Therapeutic Introduction
11.10.4 International Isotopes Revenue in Nuclear Drug for Therapeutic Business (2018-2024)
11.10.5 International Isotopes Recent Developments
11.11 Mundipharma
11.11.1 Mundipharma Company Details
11.11.2 Mundipharma Business Overview
11.11.3 Mundipharma Nuclear Drug for Therapeutic Introduction
11.11.4 Mundipharma Revenue in Nuclear Drug for Therapeutic Business (2018-2024)
11.11.5 Mundipharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Nuclear Drug for Therapeutic Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Radium-223
Table 3. Key Players of Lutetium-177
Table 4. Key Players of Iodine-131
Table 5. Key Players of Other
Table 6. Global Nuclear Drug for Therapeutic Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Nuclear Drug for Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Nuclear Drug for Therapeutic Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Nuclear Drug for Therapeutic Market Share by Region (2018-2024)
Table 10. Global Nuclear Drug for Therapeutic Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Nuclear Drug for Therapeutic Market Share by Region (2024-2029)
Table 12. Nuclear Drug for Therapeutic Market Trends
Table 13. Nuclear Drug for Therapeutic Market Drivers
Table 14. Nuclear Drug for Therapeutic Market Challenges
Table 15. Nuclear Drug for Therapeutic Market Restraints
Table 16. Global Nuclear Drug for Therapeutic Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Nuclear Drug for Therapeutic Revenue Share by Players (2018-2024)
Table 18. Global Top Nuclear Drug for Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Drug for Therapeutic as of 2022)
Table 19. Global Nuclear Drug for Therapeutic Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Nuclear Drug for Therapeutic Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Nuclear Drug for Therapeutic, Headquarters and Area Served
Table 22. Global Key Players of Nuclear Drug for Therapeutic, Product and Application
Table 23. Global Key Players of Nuclear Drug for Therapeutic, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nuclear Drug for Therapeutic Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Nuclear Drug for Therapeutic Revenue Market Share by Type (2018-2024)
Table 27. Global Nuclear Drug for Therapeutic Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Nuclear Drug for Therapeutic Revenue Market Share by Type (2024-2029)
Table 29. Global Nuclear Drug for Therapeutic Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Nuclear Drug for Therapeutic Revenue Share by Application (2018-2024)
Table 31. Global Nuclear Drug for Therapeutic Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Nuclear Drug for Therapeutic Revenue Share by Application (2024-2029)
Table 33. North America Nuclear Drug for Therapeutic Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Nuclear Drug for Therapeutic Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Nuclear Drug for Therapeutic Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Nuclear Drug for Therapeutic Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Nuclear Drug for Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Nuclear Drug for Therapeutic Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Nuclear Drug for Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Nuclear Drug for Therapeutic Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Nuclear Drug for Therapeutic Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Nuclear Drug for Therapeutic Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Nuclear Drug for Therapeutic Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Nuclear Drug for Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Nuclear Drug for Therapeutic Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Nuclear Drug for Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Nuclear Drug for Therapeutic Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Nuclear Drug for Therapeutic Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Nuclear Drug for Therapeutic Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Nuclear Drug for Therapeutic Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Nuclear Drug for Therapeutic Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Nuclear Drug for Therapeutic Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Nuclear Drug for Therapeutic Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Nuclear Drug for Therapeutic Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Nuclear Drug for Therapeutic Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Nuclear Drug for Therapeutic Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Nuclear Drug for Therapeutic Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 65. Bayer Company Details
Table 66. Bayer Business Overview
Table 67. Bayer Nuclear Drug for Therapeutic Product
Table 68. Bayer Revenue in Nuclear Drug for Therapeutic Business (2018-2024) & (US$ Million)
Table 69. Bayer Recent Developments
Table 70. Novartis Company Details
Table 71. Novartis Business Overview
Table 72. Novartis Nuclear Drug for Therapeutic Product
Table 73. Novartis Revenue in Nuclear Drug for Therapeutic Business (2018-2024) & (US$ Million)
Table 74. Novartis Recent Developments
Table 75. China Isotope & Radiation Company Details
Table 76. China Isotope & Radiation Business Overview
Table 77. China Isotope & Radiation Nuclear Drug for Therapeutic Product
Table 78. China Isotope & Radiation Revenue in Nuclear Drug for Therapeutic Business (2018-2024) & (US$ Million)
Table 79. China Isotope & Radiation Recent Developments
Table 80. Dongcheng Company Details
Table 81. Dongcheng Business Overview
Table 82. Dongcheng Nuclear Drug for Therapeutic Product
Table 83. Dongcheng Revenue in Nuclear Drug for Therapeutic Business (2018-2024) & (US$ Million)
Table 84. Dongcheng Recent Developments
Table 85. Q BioMed Company Details
Table 86. Q BioMed Business Overview
Table 87. Q BioMed Nuclear Drug for Therapeutic Product
Table 88. Q BioMed Revenue in Nuclear Drug for Therapeutic Business (2018-2024) & (US$ Million)
Table 89. Q BioMed Recent Developments
Table 90. Curium Pharmaceuticals Company Details
Table 91. Curium Pharmaceuticals Business Overview
Table 92. Curium Pharmaceuticals Nuclear Drug for Therapeutic Product
Table 93. Curium Pharmaceuticals Revenue in Nuclear Drug for Therapeutic Business (2018-2024) & (US$ Million)
Table 94. Curium Pharmaceuticals Recent Developments
Table 95. Jubilant Radiopharma Company Details
Table 96. Jubilant Radiopharma Business Overview
Table 97. Jubilant Radiopharma Nuclear Drug for Therapeutic Product
Table 98. Jubilant Radiopharma Revenue in Nuclear Drug for Therapeutic Business (2018-2024) & (US$ Million)
Table 99. Jubilant Radiopharma Recent Developments
Table 100. Lantheus Company Details
Table 101. Lantheus Business Overview
Table 102. Lantheus Nuclear Drug for Therapeutic Product
Table 103. Lantheus Revenue in Nuclear Drug for Therapeutic Business (2018-2024) & (US$ Million)
Table 104. Lantheus Recent Developments
Table 105. Aurobindo Pharma Company Details
Table 106. Aurobindo Pharma Business Overview
Table 107. Aurobindo Pharma Nuclear Drug for Therapeutic Product
Table 108. Aurobindo Pharma Revenue in Nuclear Drug for Therapeutic Business (2018-2024) & (US$ Million)
Table 109. Aurobindo Pharma Recent Developments
Table 110. International Isotopes Company Details
Table 111. International Isotopes Business Overview
Table 112. International Isotopes Nuclear Drug for Therapeutic Product
Table 113. International Isotopes Revenue in Nuclear Drug for Therapeutic Business (2018-2024) & (US$ Million)
Table 114. International Isotopes Recent Developments
Table 115. Mundipharma Company Details
Table 116. Mundipharma Business Overview
Table 117. Mundipharma Nuclear Drug for Therapeutic Product
Table 118. Mundipharma Revenue in Nuclear Drug for Therapeutic Business (2018-2024) & (US$ Million)
Table 119. Mundipharma Recent Developments
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nuclear Drug for Therapeutic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Nuclear Drug for Therapeutic Market Share by Type: 2022 VS 2029
Figure 3. Radium-223 Features
Figure 4. Lutetium-177 Features
Figure 5. Iodine-131 Features
Figure 6. Other Features
Figure 7. Global Nuclear Drug for Therapeutic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Nuclear Drug for Therapeutic Market Share by Application: 2022 VS 2029
Figure 9. Thyroid Case Studies
Figure 10. Bone Metastasis Case Studies
Figure 11. Lymphoma Case Studies
Figure 12. Other Case Studies
Figure 13. Nuclear Drug for Therapeutic Report Years Considered
Figure 14. Global Nuclear Drug for Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Nuclear Drug for Therapeutic Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Nuclear Drug for Therapeutic Market Share by Region: 2022 VS 2029
Figure 17. Global Nuclear Drug for Therapeutic Market Share by Players in 2022
Figure 18. Global Top Nuclear Drug for Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Drug for Therapeutic as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Nuclear Drug for Therapeutic Revenue in 2022
Figure 20. North America Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Nuclear Drug for Therapeutic Market Share by Type (2018-2029)
Figure 22. North America Nuclear Drug for Therapeutic Market Share by Application (2018-2029)
Figure 23. North America Nuclear Drug for Therapeutic Market Share by Country (2018-2029)
Figure 24. United States Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Nuclear Drug for Therapeutic Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Nuclear Drug for Therapeutic Market Share by Type (2018-2029)
Figure 28. Europe Nuclear Drug for Therapeutic Market Share by Application (2018-2029)
Figure 29. Europe Nuclear Drug for Therapeutic Market Share by Country (2018-2029)
Figure 30. Germany Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Nuclear Drug for Therapeutic Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Nuclear Drug for Therapeutic Market Share by Type (2018-2029)
Figure 38. China Nuclear Drug for Therapeutic Market Share by Application (2018-2029)
Figure 39. Asia Nuclear Drug for Therapeutic Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Nuclear Drug for Therapeutic Market Share by Type (2018-2029)
Figure 41. Asia Nuclear Drug for Therapeutic Market Share by Application (2018-2029)
Figure 42. Asia Nuclear Drug for Therapeutic Market Share by Region (2018-2029)
Figure 43. Japan Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Nuclear Drug for Therapeutic Market Share by Country (2018-2029)
Figure 53. Brazil Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Nuclear Drug for Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Bayer Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2018-2024)
Figure 60. Novartis Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2018-2024)
Figure 61. China Isotope & Radiation Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2018-2024)
Figure 62. Dongcheng Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2018-2024)
Figure 63. Q BioMed Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2018-2024)
Figure 64. Curium Pharmaceuticals Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2018-2024)
Figure 65. Jubilant Radiopharma Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2018-2024)
Figure 66. Lantheus Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2018-2024)
Figure 67. Aurobindo Pharma Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2018-2024)
Figure 68. International Isotopes Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2018-2024)
Figure 69. Mundipharma Revenue Growth Rate in Nuclear Drug for Therapeutic Business (2018-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries